Christopher M. Yea

2023

In 2023, Christopher M. Yea earned a total compensation of $1.7M as Chief Development Officer at Carbylan Therapeutics, a 38% decrease compared to previous year.

Compensation breakdown

Bonus$133,770
Option Awards$138,909
Salary$477,750
Stock Awards$871,479
Other$28,709
Total$1,650,617

Yea received $871.5K in stock awards, accounting for 53% of the total pay in 2023.

Yea also received $133.8K in bonus, $138.9K in option awards, $477.8K in salary and $28.7K in other compensation.

Rankings

In 2023, Christopher M. Yea's compensation ranked 692nd out of 2,978 executives tracked by ExecPay. In other words, Yea earned more than 76.8% of executives.

ClassificationRankingPercentile
All
692
out of 2,978
77th
Division
Manufacturing
392
out of 1,637
76th
Major group
Chemicals And Allied Products
267
out of 906
71st
Industry group
Drugs
262
out of 869
70th
Industry
Pharmaceutical Preparations
169
out of 627
73rd
Source: SEC filing on August 14, 2023.

Yea's colleagues

We found two more compensation records of executives who worked with Christopher M. Yea at Carbylan Therapeutics in 2023.

2023

T Crockett

Carbylan Therapeutics

Chief Executive Officer

2023

Benjamin Palleiko

Carbylan Therapeutics

Chief Financial Officer

News

You may also like